Company news
Adimmune Corporation (TWSE:4142) news
Adimmune Corporation news releases on 6ix. Latest, Aug 12, 2022: Adimmune : announces financail statements of 2022 second quarter.
Press releases & updates
Adimmune : announces financail statements of 2022 second quarter.
August 12, 2022
Adimmune : To announce the completion status of execution of the stock repurchase
August 9, 2022
Adimmune : The list of the newly elected 21st directors (including independent directors) of the Company
June 29, 2022
Adimmune : The Company's shareholders' meeting approved the release of non-compete restrictions on directors
June 29, 2022
Adimmune : The Company's board of directors re-elected Dr. Chan Chi-Hsien as the chairperson
June 29, 2022
Adimmune : Announcement of members of the Company's 3rd audit committee
June 29, 2022
Adimmune : Announcement of the board resolution to repurchase treasury shares
June 9, 2022
Adimmune : Resolution by the board of directors not to distribute dividends.
March 29, 2022
Adimmune : The board of directors approved the company's 2021 consolidated financial report.
March 29, 2022
Subject:Announcement of the approval of the Company's quadrivalent influenza vaccine from China's National Medical Products Administration
February 11, 2022
Adimmune : Change to the research and development officer of the company
January 26, 2022
Adimmune :'s Quadrivalent Flu Vaccine Approved by TFDA
May 10, 2017
Adimmune : begins shipments to EU and Phase III trial in Europe
November 23, 2016
Adimmune : Successfully Places NT$1.5 BN Guaranteed Convertible Bonds
October 21, 2016